普通外文研报
Q1/F26: Adj. EBITDA Misses On Higher Spending
研报英文原文证据摘录
Q1/F26: Adj. EBITDA Misses On Higher Spending
Health Care Services & Technology
kneat.com, inc.
TD SECURITIES INC. - CANADA QUICK TAKE: EARNINGS UPDATE
May 14, 2026
Price: C$5.09 (05/13/2026) Q1/F26: Adj. EBITDA Misses On Higher
Price Target: C$6.00 Spending
BUY (1)
ESG SCORE: 68/100
David Kwan, CFA^ THE TD COWEN INSIGHT
604 654 3455
Although KSI delivered a modest beat on revenue, it was lower quality (driven by PS). Organic
david.kwan@tdsecurities.com
growth remains strong and well above industry growth, but it continues to decelerate, while
Firuz Yakhyayev, CFA^ higher spending drove the Adj. EBITDA miss and there was a surge in A/R. We think the stock is
416 983 4186 likely to give back some of its recent sharp gains, but that the strategic review should provide
firuz.yakhyayev@tdsecurities.com
some downside support.
Key Data
Symbol TSX: KSI-T Event: After market close, KSI reported its Q1/F26 results. Conference Call: Thursday, May 14,
Market Cap C$490.4MM 9:00 a.m. ET (webcast link).
General: Insiders own ~20.5% of basic shares outstanding.
Impact: SLIGHTLY NEGATIVE; strategic review should help limit downside from the Adj.
EBITDA miss
Professional services drives revenue beat. Q1 revenue increased 22% y/y to C$18.0mm, ~2%
above our estimate and consensus. The beat was lower quality, as it was driven by much
higher-than-expected PS revenue of C$1.5mm, well above our C$0.9mm forecast. PS revenue
benefited from one large contract in particular.
Organic SaaS and ARR growth continues to decelerate. SaaS revenue grew 20% y/y to C
$16.5mm, in line with our forecast. This compares to the ~30%-40% organic growth over the
last year.
SaaS ARR grew 21% y/y to $76.4mm, also in line with our forecast. This compares to 52% y/y
growth LY and 24% y/y growth LQ.
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器